2021-01-20
- Professor Sanfilippo was one of ten new faculty hires made in the School of Molecular and Cellular Biology in the last three years. Sanfilippo is an assistant professor of biochemistry.
2021-01-20 - Professor Mera was one of ten new faculty hires made in the School of Molecular and Cellular Biology in the last three years. Mera is an assistant professor of microbiology, and is also an affiliate of the Microbial Systems Initiative.
2021-01-20 - Professor Martinez was one of ten new faculty hires made in the School of Molecular and Cellular Biology in the last three years. Martinez is an assistant professor of microbiology and statistics and is an affiliate of the Carl R. Woese Institute for Genomic Biology, as well as the Department of Evolution, Ecology, and Behavior.
2021-01-20 - Professor Kieffer was one of ten new faculty hires made in the School of Molecular and Cellular Biology in the last three years. Kieffer is an assistant professor of microbiology, and is also an affiliate of Infection Genomics for One Health (IGOH) theme at the Carl R. Woese Institute for Genomic Biology (IGB).
2021-01-20 - Professor Hatoum was one of ten new faculty hires made in the School of Molecular and Cellular Biology in the last three years. Hatoum is an assistant professor of microbiology and is part of the Microbial Systems Initiative.
2021-01-20 - Professor Auerbach was one of ten new faculty hires made in the School of Molecular and Cellular Biology in the last three years. Auerbach is an assistant professor of molecular and integrative physiology, and is also an affiliate of the Beckman Institute.
2021-01-20 - The School of Molecular & Cellular Biology is proud to have accomplished ten new faculty hires over the last three years! These strategic hires have been made in areas of brain plasticity, virology and immunology, developmental biology, and microbiology. These outstanding new recruits, together with our current accomplished faculty, will strengthen and enrich our path-breaking research...
2021-01-05 - Recent clinical trials involving Fragile X Syndrome (FXS), a genetic disorder that causes mild to severe intellectual disability, indicate that potential drug treatments are not as effective as researchers initially hoped. This lack of therapeutic potential suggests there are some gaps in our understanding of the neural mechanisms at play in FXS patients. Thanks to a new grant from the National...
2020-12-31 - “Don’t refrain from getting involved in initiatives beyond academics! Step out of your comfort zone.” - Surabhi Sonam, PhD Student in the Jonathan Henry Laboratory
2020-12-31 - Dr. Tsai’s lab focuses on understanding the molecular mechanisms underlying neuronal excitability imbalance in neurological and psychiatric disorders including epilepsy and autism.
2020-12-31 - Dr. Nelson’s lab focuses on determining how different hormones and metabolite factors impact breast and ovarian cancer progression.
2020-12-23 - New mutations to the coronavirus that causes COVID-19 are emerging, including one in the United Kingdom with higher infection rates that has sparked new travel bans. Erik Procko, a professor of biochemistry at the University of Illinois Urbana-Champaign, has been studying mutations in the spike protein, the part of the virus that binds to human cells. In an interview with News Bureau biomedical...
2020-12-21 - With support and leadership from the School of Molecular & Cellular Biology, the Microbial Systems Initiative (MSI) aims to harness the existing and emerging strengths of the microbial sciences community and establish the University of Illinois Urbana-Champaign as a leading center that will continue to attract and nurture a diverse, creative, and connected group of faculty and trainees.
2020-12-17 - It has been over 60 years since scientists first identified the molecule that we know today as immunoglobulin (Ig) A. IgA is the predominant class of antibody found in human mucus where it is known as secretory (S) IgA. SIgA functions to bind microbes in extracellular regions such as the gut and lungs where it is involved in a variety of poorly understood mechanisms that can promote both pathogen...
2020-12-14 - Current cancer treatments include drugs that target standard protein synthesis in cells, which can kill cancer cells, but also targets healthy cells. To address this issue, associate professor of biochemistry and Cancer Center at Illinois (CCIL) member, Hong Jin, is focusing on a non-canonical protein translation pathway, which will allow researchers to develop drugs with targeted specificity.